Mannarino, M.R.; Bianconi, V.; Cosentini, E.; Figorilli, F.; Colangelo, C.; Giglioni, F.; Lombardini, R.; Paltriccia, R.; Pirro, M.
Thyroid-Stimulating Hormone Predicts Total Cholesterol and Low-Density Lipoprotein Cholesterol Reduction during the Acute Phase of COVID-19. J. Clin. Med. 2022, 11, 3347.
https://doi.org/10.3390/jcm11123347
AMA Style
Mannarino MR, Bianconi V, Cosentini E, Figorilli F, Colangelo C, Giglioni F, Lombardini R, Paltriccia R, Pirro M.
Thyroid-Stimulating Hormone Predicts Total Cholesterol and Low-Density Lipoprotein Cholesterol Reduction during the Acute Phase of COVID-19. Journal of Clinical Medicine. 2022; 11(12):3347.
https://doi.org/10.3390/jcm11123347
Chicago/Turabian Style
Mannarino, Massimo Raffaele, Vanessa Bianconi, Elena Cosentini, Filippo Figorilli, Cecilia Colangelo, Francesco Giglioni, Rita Lombardini, Rita Paltriccia, and Matteo Pirro.
2022. "Thyroid-Stimulating Hormone Predicts Total Cholesterol and Low-Density Lipoprotein Cholesterol Reduction during the Acute Phase of COVID-19" Journal of Clinical Medicine 11, no. 12: 3347.
https://doi.org/10.3390/jcm11123347
APA Style
Mannarino, M. R., Bianconi, V., Cosentini, E., Figorilli, F., Colangelo, C., Giglioni, F., Lombardini, R., Paltriccia, R., & Pirro, M.
(2022). Thyroid-Stimulating Hormone Predicts Total Cholesterol and Low-Density Lipoprotein Cholesterol Reduction during the Acute Phase of COVID-19. Journal of Clinical Medicine, 11(12), 3347.
https://doi.org/10.3390/jcm11123347
